https://www.selleckchem.com/pr....oducts/fluzoparib.ht
Service use and health related quality of life data will also be collected to carry out a cost effectiveness and utility evaluation. DISCUSSION Findings from this study will inform policy regarding interventions for challenging behaviour in young children with moderate to severe intellectual disabilities. TRIAL REGISTRATION NUMBER Clinicaltrials.gov, NCT03086876. Registered 22nd March 2017, https//clinicaltrials.gov/ct2/show/NCT03086876.BACKGROUND To describe factors which influence the age at detection and age at presentation of pat
Like
Comment
Share
